Daniel Morgensztern, MD

All articles by Daniel Morgensztern, MD

Non-small cell lung cancer: Molecular targets and  emerging options for care

By

Daniel Morgensztern, MD

April 1, 2013

This activity from myCME offers a review of groundbreaking molecular research and novel treatment options for patients with NSCLC.

Next post in CE Courses

IBC diagnosis is still based on visible symptoms rather than a specific pathological test.

Inflammatory breast cancer: An atypical breast cancer type